Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
N/A
12 Years
N/A
12 Years
N/A
Open (Enrolling)
Both
Melanoma
Both
Melanoma
Trial Information
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
Inclusion Criteria:
- Age 12 or older
- Patient who has already been selected by their dermatologist for biopsy of a
suspicious pigmented lesion and who consents to participate in the study
- Signed informed consent
Exclusion Criteria:
- Age < 12 years
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Outcome Measure:
Sensitivity of confocal microscope to improve melanoma detection
Outcome Description:
Determine the sensitivity of confocal microscopy in the diagnosis of melanoma by comparison to the gold standard histopathologic diagnosis.
Outcome Time Frame:
Up to 1 year
Safety Issue:
No
Principal Investigator
Eric Simpson
Investigator Role:
Principal Investigator
Investigator Affiliation:
OHSU Knight Cancer Institute
Authority:
United States: Food and Drug Administration
Study ID:
IRB00006939
NCT ID:
NCT01556503
Start Date:
April 2011
Completion Date:
Related Keywords:
- Melanoma
- Melanoma
Name | Location |
|---|---|
| OHSU Knight Cancer Institute | Portland, Oregon 97239 |
